Detalles de la búsqueda
1.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
N Engl J Med
; 390(15): 1394-1407, 2024 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587233
2.
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med
; 390(16): 1455-1466, 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587237
3.
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med
; 389(12): 1069-1084, 2023 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37622681
4.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
Circulation
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581389
5.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Lancet
; 403(10437): 1635-1648, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599221
6.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med
; 385(16): 1451-1461, 2021 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449189
7.
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
Circulation
; 145(3): 184-193, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779658
8.
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
Circulation
; 145(3): 158-169, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34743554
9.
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.
Circulation
; 146(14): 1046-1055, 2022 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36098051
10.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
N Engl J Med
; 383(15): 1413-1424, 2020 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32865377
11.
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.
J Card Fail
; 29(10): 1345-1354, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558088
12.
Charting a roadmap for heart failure research in India: Insights from a qualitative survey.
Indian J Med Res
; 158(2): 182-189, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37787260
13.
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.
Circulation
; 143(4): 298-309, 2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33040613
14.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med
; 381(21): 1995-2008, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31535829
15.
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Circulation
; 142(11): 1040-1054, 2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32673497
16.
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.
Diabetes Obes Metab
; 23(4): 886-896, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33319454
17.
Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjectsã- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial.
Circ J
; 85(11): 2063-2070, 2021 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33980763
18.
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Eur Heart J
; 41(22): 2109-2117, 2020 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32498081
19.
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).
Eur Heart J
; 41(36): 3402-3418, 2020 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32820334
20.
The continuous heart failure spectrum: moving beyond an ejection fraction classification.
Eur Heart J
; 40(26): 2155-2163, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30957868